HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zi-Sheng Ai Selected Research

Therapeutics

8/2015Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.
10/2011Reference value of brachial-ankle pulse wave velocity for the eastern Chinese population and potential influencing factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zi-Sheng Ai Research Topics

Disease

1Necrosis
04/2022
1Renal Insufficiency (Renal Failure)
11/2015
1Heart Failure
08/2015
1Pulmonary Hypertension
08/2015
1Lung Injury
01/2015
1Poisoning
01/2015
1Tuberculosis (Tuberculoses)
02/2012
1Spinal Tuberculosis (Pott's Disease)
02/2012
1Cardiovascular Diseases (Cardiovascular Disease)
10/2011
1Wounds and Injuries (Trauma)
11/2010

Drug/Important Bio-Agent (IBA)

1Acetylcysteine (Siran)FDA LinkGeneric
11/2015
1fasudil (AT 877)IBA
08/2015
1ParaquatIBA
01/2015
1benzmetanide (H 25)IBA
02/2012

Therapy/Procedure

2Therapeutics
08/2015 - 10/2011
1Fracture Fixation
04/2022
1Bone Transplantation (Bone Grafting)
02/2012
1Debridement
02/2012
1Replantation
11/2010
1Surgical Amputation (Amputations)
11/2010